Basics Soleno Therapeutics, Inc. Common Stock Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. IPO Date: November 10, 2014 Sector: Healthcare Industry: Biotech Market Cap: $3.71B Activated in VL: True Average Daily Range Avg Daily Range: $0.40 | 3.65% Avg Daily Range (30 D): $1.87 | 2.46% Avg Daily Range (90 D): $1.48 | 1.89% Institutional Daily Volume Avg Daily Volume: .57M Avg Daily Volume (30 D): 1.23M Avg Daily Volume (90 D): 1M Trade Size Avg Trade Size (Sh.): 152 Avg Trade Size (Sh.) (30 D): 55 Avg Trade Size (Sh.) (90 D): 53 Institutional Trades Total Inst.Trades: 1,621 Avg Inst. Trade: $2.8M Avg Inst. Trade (30 D): $4.45M Avg Inst. Trade (90 D): $4.68M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $4.89M Avg Closing Trade (30 D): $9.67M Avg Closing Trade (90 D): $10.44M Avg Closing Volume: 85.18K     News Sep 7, 2025 @ 1:02 PM SLNO Investor News: If You Have Suffered Losses in... Source: Rosen Law Firm Sep 6, 2025 @ 3:00 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Danielle Peyton Aug 29, 2025 @ 2:00 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Danielle Peyton Aug 19, 2025 @ 5:38 PM INVESTOR ALERT: Investigation of Soleno Therapeuti... Source: Holzer & Holzer, Llc Aug 7, 2025 @ 12:21 AM Soleno (SLNO) Q2 Revenue Jumps 30% Source: Jesterai Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.09 $-.95 $-1.3 Diluted EPS $-.09 $-.95 $-1.3 Revenue $ 32.66M $ M $ M Gross Profit $ 31.96M $ M $ Net Income / Loss $ -4.71M $ -43.77M $ -55.98M Operating Income / Loss $ -6.53M $ -45.74M $ -59.12M Cost of Revenue $ .7M $ M $ Net Cash Flow $ -4.83M $ -6.6M $ 39.52M PE Ratio     Splits Aug 26, 2022:   1:15 Oct 06, 2017:   1:5